Abstract 1478P
Background
We have recently exploring biomarkers that could help physicians in selecting the appropriate opioid for individual patients with cancer pain. Recently, we identified, by screening subjects for 74 pain-related single-nucleotide polymorphisms (SNPs), a SNP of CCL11 (rs17809012) as one such biomarker that was significantly associated with the analgesic effect of morphine.
Methods
In the current study, we measured the plasma concentrations of several chemokines/cytokines in pre-treatment plasma samples obtained from a total of 138 patients enrolled in our clinical study who had been randomized to a morphine group (n=70) or oxycodone group (n=68). A genotypic analysis was also carried out for several SNPs of the IL-16, the only gene that was positively screened in the plasma analysis. We then used multiple linear regression models to assess whether both of the SNPs of CCL11 and of IL-16 could be combined to accurately predict which opioid might be the most suitable to provide pain relief in patients with cancer.
Results
We identified one cytokine, IL-16, whose plasma concentrations showed a clear bias between patients with cancer pain who responded well and responded poorly to oxycodone. We also confirmed that a SNP of the IL-16 gene (rs4778889) as being significantly associated with the analgesic effect of oxycodone. We then found that the SNPs of CCL11 (rs17809012) and IL-16 (rs4778889) could be used in combination for the opioid prediction. Morphine tended to provide superior analgesic effect over oxycodone in patients with the rs4778889 TT genotype and the rs17809012 AG/GG genotype (n=45), while a trend towards a better analgesic effect of oxycodone was observed in patients with other genotype combinations of the SNPs (n=93) (P=0.0012 for the interaction).
Conclusions
Our results suggest that the IL-16 rs4778889 and CCL11 rs17809012 SNPs could serve as a potential dual-biomarker combination for personalized analgesic therapy in patients with cancer pain.
Clinical trial identification
UMIN000015579.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
The Health Labor Sciences Research Grant and the Japan Agency for Medical Research and Development.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1199P - Developing and systematically validating homologous recombination repair gene detection method based on next-generation sequencing
Presenter: Yi Sun
Session: Poster session 10
1200P - Investigation of multiphoton microscopy as an innovative tool for intraoperative section-free histologic investigations in just a few minutes
Presenter: Martí Homs Soler
Session: Poster session 10
1201P - Novel deep learning model and validation of whole slide images in lung cancer diagnosis
Presenter: Alhassan Ahmed
Session: Poster session 10
Resources:
Abstract
1202P - A deep learning approach using routine pathology images to guide precision medicine in metastatic CRC
Presenter: Chaitanya Parmar
Session: Poster session 10
1203P - Analytical evaluation of whole genome sequencing for acute myeloid leukemia
Presenter: Guidantonio Malagoli Tagliazucchi
Session: Poster session 10
1204P - Real-world utility of whole genome sequencing for patients with cancer: Evaluation of a regional implementation of the 100,000 genomes project
Presenter: Helen Robbins
Session: Poster session 10
1205P - A retrospective machine learning-based analysis of nationwide cancer CGP data across cancer types to identify features associated with recommendation of mutation-based therapy
Presenter: Hiroaki Ikushima
Session: Poster session 10
1479P - Use of rescue opioids and pain control after ketamine initiation in refractory cancer pain: A multicentric observational study
Presenter: Pablo Gallardo Melo
Session: Poster session 10
1480P - Long term therapy with denosumab and zoledronic acid: A comparative real-world retrospective observational study on skeletal-related events and pain in patients with metastatic breast cancer
Presenter: Giacomo Massa
Session: Poster session 10
1481P - A case-control study of drug-eluting microspheres and blank microspheres in bronchial artery embolization for hemoptysis in non-small cell lung cancer
Presenter: Tongguo Si
Session: Poster session 10